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Copyright © 200? JCBN Summary Diabetes is one of the most common metabolic disorders worldwide. It is a major
health problem with its frequency increasing every day in most countries. The disease is
generally believed to be incurable; and the few orthodox drugs available to manage the disease
are not readily affordable to the poor. Based on the historical success of natural products as
antidiabetic agents and the ever increasing need for new antidiabetics, a number of South
African medicinal plants have been evaluated for their antidiabetic properties. In this article,
we review the major studies conducted based on ethnobotanical surveys carried out between
2005 and 2008 in South Africa on plants that are traditionally used for the treatment of
diabetes. Overall, the results of the studies conducted confirmed the potential of South African
medicinal plants in antidiabetic drug discovery and identified a number of promising taxa for
further in vivo investigation as plant-based antidiabetic agents.
Key Words:diabetes, herbal medicines, antidiabetic, plant extract, blood glucose
Introduction
The word diabetes is borrowed from the Greek word
meaning a siphon because the affected individuals experience
polyuria and pass water like a siphon. Diabetes could either
be mellitus or less often, insipidus. However, when the term
is used without qualification, it usually refers to diabetes
mellitus.
Diabetes mellitus is a metabolic disease characterized by
high blood glucose level resulting from defects in insulin
secretion, insulin action or both [1]. It is a chronic disorder
that affects the metabolism of carbohydrates, fats, proteins
and electrolytes in the body, leading to severe complications
which are classified into acute, sub-acute and chronic [2].
Acute complications include hypoglycemia, diabetic keto-
acidosis, hyperosmolar and hyperglycaemic non-ketotic
syndrome [3] while sub acute complications include thirst,
polyuria, lack of energy, visual blurriness and weight loss
[4]. Chronic hyperglycemia causes glycation of body pro-
teins which in turn leads to complications that may affect
the eyes, kidneys, nerves and arteries [5].
Diabetes insipidus, on the other hand, is a disorder that is
associated with lack of vasopressin and characterized by an
abnormal increase in urine output, fluid intake, frequent
urination and excessive thirst [6]. Vasopressin is an anti-
diuretic hormone formed in the hypothalamus and secreted
by the pituitary gland. The hormone is used primarily to
control water retention through the reduction in urine output.
Although both diabetes mellitus and insipidus share some
common symptoms such as frequent urination and excessive
thirst, the diagnosis and treatment are not the same [6].
On the basis of aetiology and clinical presentation,
diabetes mellitus is classified into two. Type 1, known as
insulin-dependent diabetes mellitus (IDDM) is caused by
immunological destruction of pancreatic β cells resulting in
insulin deficiency [7]. Its pathogenesis involves environ-
mental triggers that may activate autoimmune mechanisms
in genetically susceptible individuals, leading to progressive
loss of pancreatic islet β cells [8]. Many of the acute effects
of this disease can be controlled by insulin replacement
therapy; however it has long term adverse effects on bloodAntidiabetic Plants in South African Herbal Medicine
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vessels, nerves and other organs of the body [9].
Type 2, also known as non insulin-dependent diabetes
mellitus (NIDDM) is characterized by both impaired insulin
secretion and insulin resistance, which is often associated
with obesity and hereditary disposition [10]. It is increasing
rapidly and is becoming a significant global health problem
[11]. Type 2 diabetes can lead to cardiovascular damage
through a number of mechanisms, each of which in turn
may accelerate or worsen the others [12]. Despite numerous
research efforts, the nature of the defect is yet to be deter-
mined. Some patients have abnormal insulin receptor and/or
defective insulin signaling while no defects have been
identified in others. Generally, NIDDM is controlled through
dietary therapy, exercise and hypoglycemic agents [13–15].
In the last few years there has been an exponential growth
in the field of herbal medicine and these drugs are gaining
popularity both in developing and developed countries
because of their natural origin and less side effects [16].
Herbal medicines continue to play an important role in
diabetic therapy, particularly in the developing countries
where most people have limited resources and do not have
access to modern treatment [17]. WHO has also authenti-
cated the use of herbal remedies for the treatment of diabetes
[18]. The increase in demand for the use of plant based
medicines to treat diabetes may be due to the side effects
associated with the use of orthodox drugs such as insulin and
oral hypoglycemic agents [19]. Another important factor
that strengthens the use of plant materials as antidiabetics
could be attributed to the belief that herbs do provide some
benefits over and above allopathic medicine and allow the
users to feel that they have some control in their choice of
medication [20].
In South Africa, 32 plant species have been identified for
the treatment of diabetes based on the major ethnobotanical
surveys documented by Erasto et al. [21]; Thring and Weitz
[22]; Van Wyk et al. [23]; van de Venter et al. [24] and Van
Wyk [25, 26] (Table 1). These surveys covered the Eastern
and Western Cape Provinces, Southeastern Karoo, Khoi-San
and Cape Dutch regions which are recognized as the richest
flora communities in South Africa. Out of these flora, only
nine species have been documented in scientific literature
to possess in vivo antidiabetic activity. Basic researches
relating to these plants are reviewed in this paper with a view
to highlighting the potential of South African medicinal
plants in antidiabetic drug discovery and the need for further
in vivo investigations on antidiabetic plants.
Prevalence of Diabetes among Human Populations
Diabetes is a common and very prevalent disease affecting
the citizens of both developed and developing countries.
The WHO estimated the disease in adults to be around 173
million in 2000, two-thirds of which live in developing
countries [27]. The prevalence of diabetes mellitus is on the
increase worldwide and it is still expected to increase by
5.4% in 2025 [28]. Increase in sedentary lifestyle, consump-
tion of energy-rich diet and obesity are some of the factors
causing the rise in the number of diabetics. According to the
American Diabetes Association [29], Asia and Africa are
regions with greatest potential where diabetics could rise to
two or threefold above the present level. In South Africa, the
number of people suffering from diabetes has been rising
steadily over the past two decades. Several reports have
stressed the high mortality from diabetes especially among
the black populations [30,  31]. Despite these alarming
statistics, diabetes still remain one of the age long chronic
diseases of human race and its frontiers are expanding by
the day.
Relevance of in vivo Study in Diabetic Research
Diabetes affects many metabolic pathways in human
tissues, many of which are potential targets for drug treat-
ment [24]. Most of the studies on antidiabetic plants are
focused on in vitro analysis. Unfortunately, this approach
complicates the identification of new treatments, as most in
vitro screening models consider single cell types, metabolic
pathway or enzyme; thus greatly reducing the possibility
of identifying antidiabetic plant extracts or compounds.
Another disadvantage of in vitro studies is that only acute or
immediate effects are measured, whilst effects that may only
be apparent after chronic exposure to the antidiabetic
compounds are overlooked [24]. In this regard, animal
models are more appropriate for the evaluation of anti-
diabetic properties of medicinal plants.
South Africa is home to over 30,000 species of higher
plants and 3,000 of these species are used in traditional
medicine across the country [32]. According to Mander,
there are over 27 million users of indigenous medicine [33];
and an estimated 200,000 indigenous traditional healers
that treat up to 60% of the population [32]. Hence, there is
the need to carry out in vivo studies on medicinal plants with
a view to validating their acclaimed efficacy and evaluating
their toxic potentials.
Plants with Documented in vivo Antidiabetic Activities
Vernonia amygdalina Del. (Asteraceae)
Vernonia amygdalina commonly known as bitter leaf, is a
small tree growing up to 3 m high. It occurs wild in most
countries of tropical Africa. In South Africa, the plant is
found in KwaZulu Natal, Mpumalanga, Eastern and
Northern Cape Provinces [34]. It is probably the most used
plant in the genus Vernonia. The common and documented
medicinal uses include the treatment of schistomiasis,
amoebic dysentery and gastrointestinal problems [35]. It isA.J. Afolayan and T.O. Sunmonu
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also used in the treatment of malaria, venereal diseases,
wounds, hepatitis and diabetes [36–41]. The leaves may be
consumed either as a vegetable or aqueous extracts as tonics
for the treatment of various illnesses.
Until the last decade, there were only anecdotal reports
and claims to support the antidiabetic activity V. amygdalina.
Gyang et al. [42] reported that chloroform extract of the
plant has hypoglycaemic activity in both normoglycemic
and alloxan-induced hyperglycemic rats. Ebong et al. [43]
also reported the antidiabetic efficacy of combined ethanolic
extracts of Azadirachta indica (neem) and V. amygdalina in
rats. The decrease in blood glucose for the animals treated
with combined extracts and bitter leaf only compared
well with chlorpropamide and non-diabetic control, but not
with neem alone. This finding corroborated the report of
Atangwho et al. [44] who observed significant hypoglycemic
Table 1. Documented antidiabetic plants used in South African herbal medicine
Species Parts used References
Artemisia afra Jacq. Ex Willd. Leaves, roots Erasto et al., 2005
Leaves Thring and Weitz, 2006
Leaves Van Wyk, 2008b
Brachylaena discolor DC. Leaves, Erasto et al., 2005
Leaves, roots, stem van de Venter et al., 2008
Brachylaena elliptica Thunb. Leaves Van Wyk, 2008a
Bulbine natalensis Mill. Roots Erasto et al., 2005
Bulbine frutescens L. Roots Erasto et al., 2005
Cannabis sativa L. Leaves van de Venter et al., 2008
Catha edulis Forrsk. Ex Endl. Leaves, stems, roots van de Venter et al., 2008
Catharanthus roseus (L) G. Don. Leaves Erasto et al., 2005
Leaves, twigs van de Venter et al., 2008
Chilianthus olearaceus Burch. Leaves, twigs Erasto et al., 2005
Chironia baccifera L. Whole plant van de Venter et al., 2008
Cissampelos capensis L.f. Leaves van de Venter et al., 2008
Conyza scabrida DC. Leaves Thring and Weitz, 2006
Elytropappus rhinocerotis (L.f.) Leaves Thring and Weitz, 2006
Galium tomentosum Thunb. Roots Van Wyk et al., 2008
Herichrysum nudifolium L. Leaves, roots Erasto et al., 2005
Herichrysum odoratissimum L. whole plant Erasto et al., 2005
Herichrysum petiolare H & B.L. whole plant Erasto et al., 2005
Heteromorphica arborescens H. Leaves, roots Erasto et al., 2005
Hypoxis colchicifolia Bak. Corms Erasto et al., 2005
Hypoxis hemerocallidea Fisch. Corms Erasto et al., 2005
Leonotis leonurus L. Leaves, flowers Thring and Weitz, 2006
Momordica balsamina L. Stem, flowers van de Venter et al., 2008
Momordica foetida Schumach. Whole plant van de Venter et al., 2008
Petroselenium crispum (Mill) Leaves Thring and Weitz, 2006
Psidium guajava L. Leaves, roots van de Venter et al., 2008
Ricinus communis L. Leaves Thring and Weitz, 2006
Ruta graveolens L. Leaves Thring and Weitz, 2006
Leaves Van Wyk, 2008a
Sclerocarya birrea Hochst. Stem, bark, roots van de Venter et al., 2008
Stem, bark Van Wyk, 2008b
Sutherlandia frutescens L. Leaves Van Wyk, 2008b
Vinca major L. Leaves, roots, stem van de Venter et al., 2008
Vernonia oligocephala Sch. Bip. Leaves, twigs, roots Erasto et al., 2005
Leaves Thring and Weitz, 2006
Vernonia amygdalina Del. Leaves Erasto et al., 2005Antidiabetic Plants in South African Herbal Medicine
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activity in diabetic rats treated with V. amygdalina. Osinubi
[45] also reported that the extract of V. amygdalina produced
significant reductions in the blood glucose concentrations of
normal and diabetic rats; 1 to 12 h after the acute treatment.
In another study involving healthy human subjects, Okolie
et al. [46] investigated the hypoglycemic effects of the plant
and observed a positive disposition of the plant extract
towards the treatment of diabetes. Hence, the authors
encouraged diabetic patients to consume the vegetable for
therapeutic purposes.
Hypoxis hemerocallidea Fisch. (Hypoxidaceae)
Hypoxis hemerocallidea is one of the frequently used
African medicinal plants. The plant grows in the wild in
the area stretching from the Eastern Cape through to
KwaZulu-Natal Provinces, Lesotho, Gauteng, Mozambique,
Limpopo, Zimbabwe and even further north into East Africa
[32]. This medicinal plant of southern Africa origin is a
tuberous, perennial herb with long, strap-shaped leaves and
yellow, star-shaped flowers. The broad and slightly hairy
leaves of H. hemerocallidea are arranged one above the
other to form three distinct groups of leaves spreading
outwards from the centre of the plant, while the bright
yellow, star-shaped flowers are borne on long, slender stalks
[47]. The tuberous rootstock (corm) of the herb, which is
commonly known as ‘African Potato’, is widely used in
southern African traditional medicine as a remedy for an
array of human ailments. The plant is claimed to be an
effective remedy against HIV/AIDS-related diseases,
arthritis, yuppie flu, hypertension, diabetes mellitus, cancer,
psoriasis, gastric and duodenal ulcers, tuberculosis, urinary
tract infections, asthma, and some central nervous system
disorders especially epilepsy and childhood convulsions
[47–52].
Very little scientific reports are available on the anecdotal
claim of the antidiabetic property of H. hemerocallidea.
In separate studies by Zibula & Ojewole and Ojewole,
evaluation of the antidiabetic activity of aqueous extracts
of the plant on streptozotocin (STZ) induced diabetic rats
revealed significant reductions in the blood glucose concen-
tration of the animals [53, 54]. It was concluded that the
plant extract, like glibenclamide, induces hypoglycemia by
stimulating insulin release thereby enhancing the cellular
uptake and utilization of glucose in the animals. In another
study by Mahomed and Ojewole, aqueous extract of the
plant caused 30.20% and 48.54% reductions in the blood
glucose concentrations of fasted normal and STZ-treated
diabetic rats. The authors attributed the hypoglycemic
effect of the plant extract to its phytosterols and/or sterolin
contents [55]. The results of these animal studies indicate
that African potato possesses hypoglycemic activity; and
thus lends credence to the suggested folkloric use of the herb
in the control and/or management of diabetes mellitus in
some communities of South Africa. Another report by
Musabayane et al. however, suggested that aqueous extract
of the plant may impair kidney function [56].
Catharanthus roseus (L) G. Don (Apocynaceae)
Catharanthus roseus (also known as Vinca rosea or Vinca
multiflora) originated from Madagascar, hence the name
Madagascar periwinkle. However, the plant has now spread
throughout the tropics and subtropics (including South
Africa) by human activities. It has readily naturalized in
most places where it was introduced [32]. When it was
discovered by the Europeans, the plant was wrongly classed
as Vinca or true periwinkle. This error was later corrected,
and the plant was put in its own genus (Catharanthus). It is
a semiwoody evergreen perennial, usually cultivated as
annual in flower beds. In frostfree climates, it develops a
woody stem near the base and can grow up to 1 m tall and
spread just as wide [47]. The plant is grown commercially
for its medicinal uses in Australia, Africa, India and
southern Europe where it is used primarily in the traditional
setting to treat diabetes.
Numerous animal studies have shown that ethanolic
extracts of the leaves and flowers of C. roseus lower blood
glucose levels [57–59]. Research findings have also shown
that while the aqueous leaf extract of the herb could lower
blood glucose by about 20% in diabetic rats, dichloro-
methane and methanol extracts lowered blood glucose by
49–58% [60]. Significant increase in glucokinase activity
was reported in the liver of rats treated with the leaf extract
of C. roseus and it was suggested that the increase in glucose
utilization could be the mechanism of antidiabetic activity of
the extract [60]. Rats pretreated with the alcoholic extract
became completely immune to the diabetes-inducing effect
of streptozotocin, while the aqueous extract had only minor
preventive effect [58]. The hypoglycemic effects appeared
to be the result of increased glucose utilization in the liver.
No adverse effects were observed in the animals treated with
the extract of the plant except that serum acid and alkaline
phosphatase levels were elevated in both untreated diabetic
and treated diabetic rats. The 70% ethanolic leaf extract of
the herb given orally at 400 mg/kg was 20% as effective as
tolbutamide in diabetic rats, though the extract was much
safer [61]. The sap from fresh leaves of this plant was also
reported to reduce blood glucose in alloxan-treated rabbits
[62]. Overall, no major toxicity was observed in the diabetic
rats treated with the extract from C. roseus [60]. However,
the duration of treatment was short and the authors
suggested that chronic toxicity should be investigated for
human use.
Leonotis leonurus L. (Lamiaceae)
Leonotis leonurus is also known as lion’s tail, lion’s ear or
wild dagga. It is native to southern Africa; common at forestA.J. Afolayan and T.O. Sunmonu
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margins, on rocky hillsides, river banks and in tall grassland
especially in the Eastern and Western Cape, Kwazulu-Natal
and Mpumalanga Provinces [63]. It is a shrub of 2–5 m tall,
branching from a thick woody base with a pale brown and
densely pubescent stem. The leaves are simple, opposite,
petiolate, coriaceous, linear, acute at apex and base; and
serrate in the distal half. The upper surface of the leaf is
bright green and the lower surface densely pubescent [63].
Traditionally, the plant is used for the treatment of cough,
cold, influenza, chest infections, diabetes, hypertension,
eczema, epilepsy, delayed menstruation, intestinal worms,
constipation, spider bites, scorpion stings and as an antidote
for snakebite.
Not much has been done to validate the reported in vivo
antidiabetic activity of L. leonorus. Ojewole reported that
aqueous leaf extract of the plant caused significant hypo-
glycemic effect in rats which was attributed to the different
flavonoids, diterpenoids, polyphenolics and other chemical
constituents of the extract [64]. It is pertinent to state that the
results of this study lend pharmacological credence to the
folkloric use of the herb in the management and/or control of
diabetes in some communities in South Africa. Maphosa
et al. [65] however reported that the aqueous shoot extract
of the herb produced adverse hematological, biochemical
and histopathological changes in rats. The authors therefore
concluded that caution must be exercised in the use of the
plant for medicinal purposes.
Catha edulis Forrsk. Ex Endl. (Celastraceae)
Catha edulis popularly called khat is an evergreen shrub
of the tropics [66, 67]. The fresh leaf is traditionally chewed
by some people in East Africa and the Arabian Peninsula
to attain a state of euphoria and stimulation [68, 69]. Since
the leaf rapidly loses its effect upon wilting, the chewing
habit has remained endemic to the areas where the plant is
cultivated. During the last decades, however, due to the
development of road networks and the availability of air
transport, the habit has spread considerably in those regions
and countries where the plant does not grow. This is
probably the means by which the herb found its way into
South Africa.
Although van de Venter et al. [24] reported moderate in
vitro antidiabetic property of C. edulis, there is no published
scientific article substantiating this claim in animal models.
Contrary to this, Saif-Ali et al. [70] in a study involving
human subjects, observed an insignificant increase in blood
glucose concentration in type 2 diabetic khat chewers. The
authors attributed the effect to an indirect sympathomimetic
action.
Momordica foetida Schumach. (Cucurbitaceae)
Momordica foetida is a perennial climbing herb with
tendrils. The flowers are cream, often with a reddish or
orange centre, having the male and female flowers on the
same plant. The characteristic fruit is bright orange with
prickles and the plant has a strong unpleasant smell [71].
The herb is used to treat a number of ailments including
hypertension, diabetes mellitus, fever and symptoms of
malaria [72].
Very little has been done to establish the in vivo anti-
diabetic property of M. foetida. Marquis et al. [73] investi-
gated the effect of foetidin, isolated from the plant on blood
glucose levels of fasting and alloxan-treated rats. The
authors reported that the compound exhibited hypoglycemic
effect in normal but not in diabetic rats. The unsatisfactory
action in alloxan-treated rats was attributed to the absence of
synergistic compounds which may be present in the whole
plant or fruits as used in folkloric medicinal preparations.
Sclerocarya birrea (A. Rich.) Hochst. (Anacardiaceae)
Sclerocarya birrea is one of the most highly valued
indigenous trees in southern Africa [74]. It grows up to 15 m
high with grey fissured bark, stout branchlets and pale
foliage. The leaves are compound, pinnate and the flowers
greenish-white or reddish. The fruits are yellow and closely
resemble the mango fruits. The pulp of the fruit is delicious
and the large nut is also edible. In Africa, the tree is
commonly found in savannah regions and its geographical
distribution stretches from Gambia in the west across to
Nigeria and Cameroon, in Central Africa, and to Ethiopia
and Sudan in the east [75]. In South Africa, the plant is
commonly found in the Northern Province [76]. The Zulu
people use the bark decoction to treat diarrhoea, dysentery,
fevers, stomach ailments, ulcers and bacterial-related
diseases [48, 52, 74]. Traditional Zulu healers wash in bark
decoctions before treating patients with gangrenous rectitis
and also administer the decoction to the patient [77].
Quite a number of studies have been carried out to
establish the antidiabetic activity of S. birrea in animal
models. Ojewole reported the hypoglycemic effect of
aqueous stem-bark extract of the plant in normal and STZ-
treated diabetic rats [78]. In another study by Dimo et al.,
a methanol/methylene chloride (1:1) extract of the plant
reduced blood glucose and increased plasma insulin levels in
diabetic rats [79]. The extract also prevented body weight
loss and reduced plasma cholesterol, while the triglyceride
and urea levels tended towards normal levels. The diabetic
rats also showed significant improvement in glucose
tolerance following the administration of the extract.
Gondwe et al. also investigated the hypoglycemic effect of
the stem bark extract of the herb in normal and diabetic rats
alongside the major complications of diabetes. Whereas the
extract exhibited dose-dependent reduction in blood glucose
level, the same extract did not significantly alter kidney
function; and the blood pressure was reduced in all the
animals. The authors concluded that stem bark extract ofAntidiabetic Plants in South African Herbal Medicine
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S. birrea has reno- and cardio-protective effects in diabetic
animals [80]. These observations thus lend credence to the
folkloric use of the plant in the management and/or control
of adult-onset diabetes in some African communities.
Psidium guajava Linn. (Myrtaceae)
Psidium guajava is a tree of about 10 m high with thin,
smooth, patchy and peeling bark. Its leaves are opposite with
short-petiolates and the blades are oval with prominent
pinnate veins about 5–15 cm long. Flowers are somewhat
showy, petals are whitish and up to 2 cm long with numerous
stamens [81]. Fruits are fleshy and about 5 cm in diameter
with edible pink mesocarp containing numerous small hard
white seeds. The plant is considered a native to Mexico [82],
however it has extended throughout the South America,
Europe, Africa and Asia. Based on archaeological evidence,
the plant has been used widely and known in Peru since pre-
Columbian times [81]. It grows in all the tropical and
subtropical areas of the world, and adapts to different
climatic conditions but prefers dry climates.
The antidiabetic property of P. guajava bark, leaves and
fruits has been studied by several authors. The aqueous
leaf extract was tested by Mukhtar et al. [83] and Ojewole
[84] in alloxan-induced and STZ-induced diabetic rats
respectively. The authors attributed the observed hypo-
glycemic effect of the extract to tannins, flavonoids,
pentacyclic triterpenoids, guiajaverin, quercetin and other
chemical compounds present in the plant. In another study,
Mukhtar  et al. [ 85] examined the anti-hyperglycemic
activity of the ethanol extract obtained from the stem bark of
the plant on blood glucose levels of normal, alloxan-induced
hyperglycemic and normal glucose loaded rats. The results
showed that the extract exhibited significant hypoglycemic
activity but was devoid of hypoglycemic effect in normal
and glucose loaded rats. The butanol-soluble fraction of
the leaves also demonstrated antidiabetic property in
Leprdb/Leprdb mice [86]. Another study by Wang et al. [87]
revealed significant inhibition of alpha-glucosidase activity
in the small intestine of diabetic mice that were administered
with the leaf extract of the herb.
Sutherlandia frutescens Linn. (Fabaceae)
Sutherlandia frutescens is a popular plant in traditional
medicine. It is indigenous to South Africa, Lesotho,
southern Namibia and southeastern Botswana. In South
Africa, it is widespread in the drier areas of the South
Western and Northern Cape Provinces [88]. The plant
belongs to the Legume family which is the third largest
family of flowering plants. It is a lax spreading shrub and
approximately 1.2 m in height, with prostrate to erect stems.
The leaves are compound pinnate with leaflets oblong to
linear-elliptic, slightly to densely hairy, the latter silvery
in appearance. S. frutescens flowers between July and
December and the flowers are bright scarlet. The fruits are
inflated leathery pods, bearing persistent upturned style; and
seeds are black and flattened. The plant is generally regarded
as the most beneficial of the medicinal plants in southern
Africa, and has thus been used by all cultures including the
San, Khoi, Sotho and Nguni-speaking people [88].
Very little has been reported on the antidiabetic activity of
S. frutescens. Ojewole reported the hypoglycemic effect of
aqueous shoot extract of the plant in STZ-induced diabetic
rats [89]. Similar finding was reported by Chadwick et al. in
rats fed with diabetogenic diet. The extract demonstrated
ability to normalize insulin levels and glucose uptake in
peripheral tissues and suppresses intestinal glucose uptake
[90].
Conclusion
In South Africa, the number of people suffering from
diabetes has been rising steadily over the past two decades.
This high prevalence deserves special attention towards
the treatment of diabetes. The few orthodox management
options available are expensive and often associated with
negative side effects; therefore, the use of indigenous
medicinal plants provides better alternative which are
usually less toxic and affordable. Out of the 32 identified
medicinal plants traditionally used in South Africa for the
treatment of diabetes, only nine have been documented in
scientific literature to have demonstrated some in vivo
antidiabetic activity. Considering the rich cultural traditions
of plant use and the high prevalence of diabetes mellitus
in South Africa, more in vivo investigations should be
encouraged in order to validate the antidiabetic activity of
the identified plants as claimed by the traditional healers.
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